Applied Genetic Technologies Corporation
FORMULATION OPTIMIZATION FOR VIRAL PARTICLES

Abstract:

The present disclosure provides formulations for maintaining viral particles in a stable form. In certain embodiments, the formulation comprises at least one basic amino acid and a buffer solution, wherein the viral particle is present at a concentration of about 1.times.10.sup.11 to about 5.times.10.sup.13 DNase resistant virus particles per mL.